Precision Medicine in Oncology

Advancements in cancer genomics have led to a new era of precision medicine in oncology. It is now commonplace for a patient ′s tumor to be extensively profiled for molecular abnormalities, and anticancer treatments to be based mainly on the identified underlying alterations, rather than just cancer histology. This capability is a critical advance in cancer medicine since molecularly targeted agents may ultimately only benefit patients when their tumors are molecularly characterized and rationally matched with an antitumor agent with known mechanisms of action.
Source: Current Problems in Cancer - Category: Cancer & Oncology Authors: Tags: SI: Precision Medicine in Oncology Source Type: research